Free Trial

Kelly CRISPR & Gene Editing Technology ETF (XDNA) Chart & Stock Price History

Kelly CRISPR & Gene Editing Technology ETF logo
$7.38 0.00 (0.00%)
As of 05/4/2026

The Kelly CRISPR & Gene Editing Technology ETF (XDNA) fund chart highlights key performance trends across multiple timeframes. Over the last 12 months, the fund's price has remained steady at 0.00%, with a year-to-date return of 0.00%. In the past month, the fund has remained steady at 0.00%, reflecting recent market activity.

Receive XDNA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Kelly CRISPR & Gene Editing Technology ETF and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

XDNA Stock Chart for Tuesday, May, 5, 2026

Kelly CRISPR & Gene Editing Technology ETF Stock Price History

No price data in the selected date range.


This page (NASDAQ:XDNA) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners